Rekah Pharmaceutical Industry Ltd (TA:REKA) — Stock Price

ILA1060.00 ILA
▲ 1.44% today

Rekah Pharmaceutical Industry Ltd (TA:REKA) is currently trading at ILA1060.00 ILA, up 1.44% today. Over the past 52 weeks, shares have ranged between ILA1007.00 and ILA1300.00. This page tracks Rekah Pharmaceutical Industry Ltd's live share price on the TA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Rekah Pharmaceutical Industry Ltd.

Rekah Pharmaceutical Industry Ltd (REKA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Rekah Pharmaceutical Industry Ltd's daily closing share price and trading volume on the TA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Rekah Pharmaceutical Industry Ltd Income Statement — Revenue, Profit & Earnings by Year

Rekah Pharmaceutical Industry Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue ILA300.99 Million ILA321.71 Million ILA321.66 Million ILA292.39 Million ILA263.95 Million
Cost of Revenue ILA242.82 Million ILA249.76 Million ILA241.46 Million ILA213.69 Million ILA198.79 Million
Gross Profit ILA58.17 Million ILA71.95 Million ILA80.20 Million ILA78.70 Million ILA65.16 Million
Research & Development ILA4.33 Million ILA4.07 Million ILA3.78 Million ILA3.23 Million ILA2.08 Million
SG&A ILA15.91 Million ILA10.81 Million ILA30.69 Million ILA8.54 Million ILA6.41 Million
Total Operating Expenses ILA64.43 Million ILA55.58 Million ILA77.25 Million ILA65.45 Million ILA51.02 Million
Operating Income ILA-6.26 Million ILA16.37 Million ILA2.96 Million ILA13.25 Million ILA14.14 Million
EBITDA ILA24.51 Million ILA47.30 Million ILA26.03 Million ILA40.73 Million ILA35.77 Million
EBIT ILA-6.26 Million ILA14.64 Million ILA2.91 Million ILA13.25 Million ILA12.91 Million
Interest Expense ILA7.57 Million ILA6.71 Million ILA9.99 Million ILA6.47 Million ILA5.98 Million
Income Before Tax ILA-11.20 Million ILA7.93 Million ILA-7.05 Million ILA357.00K ILA7.71 Million
Income Tax Expense ILA6.88 Million ILA1.72 Million ILA-138.00K ILA2.40 Million ILA1.10 Million
Net Income ILA-18.07 Million ILA6.21 Million ILA-6.91 Million ILA-2.04 Million ILA6.62 Million

Rekah Pharmaceutical Industry Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Rekah Pharmaceutical Industry Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets ILA423.68 Million ILA447.22 Million ILA484.72 Million ILA448.42 Million ILA437.09 Million
Total Current Assets ILA232.68 Million ILA229.05 Million ILA251.33 Million ILA243.14 Million ILA221.66 Million
Cash & Equivalents — — — — —
Short-term Investments ILA39.00K ILA39.00K ILA39.00K ILA80.00K ILA39.00K
Net Receivables ILA135.40 Million ILA129.35 Million ILA117.68 Million ILA120.71 Million ILA107.37 Million
Inventory ILA91.22 Million ILA82.48 Million ILA96.60 Million ILA92.20 Million ILA89.61 Million
Property, Plant & Equipment — — — — ILA177.00 Million
Goodwill — — ILA35.14 Million ILA15.18 Million —
Total Liabilities ILA279.47 Million ILA285.24 Million ILA329.14 Million ILA286.34 Million ILA264.02 Million
Total Current Liabilities ILA151.87 Million ILA158.04 Million ILA143.79 Million ILA139.03 Million ILA98.61 Million
Long-term Debt ILA68.50 Million ILA63.62 Million ILA110.09 Million ILA91.66 Million ILA101.23 Million
Net Debt ILA128.05 Million ILA127.13 Million ILA159.59 Million ILA134.17 Million ILA147.22 Million
Total Stockholder Equity ILA144.16 Million ILA161.93 Million ILA155.54 Million ILA162.03 Million ILA173.01 Million
Retained Earnings ILA3.39 Million ILA21.19 Million ILA14.66 Million ILA21.35 Million ILA32.73 Million

Rekah Pharmaceutical Industry Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Rekah Pharmaceutical Industry Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow ILA12.95 Million ILA26.54 Million ILA28.35 Million ILA39.00 Million ILA21.17 Million
Capital Expenditures ILA7.03 Million ILA8.70 Million ILA11.49 Million ILA7.48 Million ILA13.99 Million
Free Cash Flow ILA5.92 Million ILA17.84 Million ILA16.86 Million ILA31.52 Million ILA7.17 Million
Investing Cash Flow ILA-6.29 Million ILA15.29 Million ILA-21.50 Million ILA-13.45 Million ILA-35.90 Million
Financing Cash Flow ILA-9.37 Million ILA-54.13 Million ILA-7.78 Million ILA-24.36 Million ILA-2.78 Million
Dividends Paid — — — ILA-10.00 Million —
Stock-Based Compensation ILA38.00K ILA-136.00K ILA191.00K ILA397.00K ILA445.00K
Depreciation ILA30.77 Million ILA32.66 Million ILA29.84 Million ILA27.48 Million ILA22.86 Million
Change in Cash ILA-2.69 Million ILA-12.28 Million ILA-898.00K ILA1.60 Million ILA-18.29 Million

Rekah Pharmaceutical Industry Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Rekah Pharmaceutical Industry Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 09, 2025 — — —